You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 9,941,931


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,941,931
Title:System for supply chain management
Abstract: A system for tracking a product from origin to destination is disclosed. The system includes a probe that comprises two plates, a power source and a processor. The power source is controlled by the processor to produce an oscillating output at the plates. Using the oscillating voltage, the probe interrogates a device through capacitive coupling. The device includes a control unit, a memory unit, and first and second materials physically associated with the device for communication using capacitive coupling. Information associated with the device is transferred from the device to the probe through capacitive coupling between the first and second materials and the first and second plates, respectively.
Inventor(s): Zdeblick; Mark J. (Portola Valley, CA)
Assignee: PROTEUS DIGITAL HEALTH, INC. (Redwood City, CA)
Application Number:14/491,226
Patent Claim Types:
see list of patent claims
Composition; Device;
Patent landscape, scope, and claims:

United States Patent 9,941,931: A Detailed Analysis of Scope and Claims

Introduction

The United States Patent 9,941,931, titled "System for Supply Chain Management," is a significant innovation in the field of product tracking and supply chain management. This patent, granted to inventors who developed a method and system for tracking products from origin to destination, is particularly relevant in industries such as pharmaceuticals and medical supplies.

Background and Context

The patent addresses a critical need in supply chain management: the ability to track and verify the authenticity of products. This is especially crucial in the pharmaceutical industry, where counterfeit products can have severe consequences. The system described in the patent uses electronic devices to ensure the integrity and validity of products throughout the supply chain[1].

Key Components of the Patent

Capacitive Coupling System

The patent describes a system that utilizes capacitive coupling to communicate between devices. This system includes a device with materials deposited on its surface, which are capacitively coupled to probes. These probes, powered by an AC source, can communicate with the device to verify its identity and authenticity[1].

Materials and Probes

The materials used in this system are typically conductive inks, such as graphite or carbon-based inks. These materials are deposited on the device and are in communication with a control module. When the probes are brought close to these materials, they can read and communicate the information stored in the device's memory[1].

Application in Supply Chain Management

The system is designed to track products through various stages of the supply chain, including manufacturing, pharmacy verification, and prescription processes. It ensures that only valid and authentic products are accepted, thereby preventing counterfeit products from entering the supply chain[1].

Scope of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims cover the method of using electronic devices to track products, the specific configuration of the capacitive coupling system, and the materials used in the device. The independent claims are crucial as they delineate what is considered novel and non-obvious about the invention[3].

Claim Length and Count

Research on patent scope suggests that the length and count of independent claims can be indicative of the patent's breadth and complexity. In this case, the patent's claims are detailed and specific, reflecting a narrow yet robust scope that ensures the system's functionality and uniqueness[3].

Patent Landscape

Prior Art and Related Patents

The patent builds upon prior art related to ingestible devices and other tracking systems. It references several PCT applications that describe similar technologies, but the current patent introduces a novel method of capacitive coupling for product verification[1].

Global Dossier and Patent Family

Using the Global Dossier service provided by the USPTO, one can see the patent family for this application, including related applications filed at participating IP Offices. This helps in understanding the global reach and relevance of the patent[4].

Legal and Practical Considerations

Inventorship

The determination of inventorship is a critical aspect of patent law. For this patent, the inventors must have conceived the idea of using capacitive coupling for product tracking and reduced it to practice. Ensuring correct inventorship is essential to maintain the patent's enforceability[2].

Patent Enforcement and Litigation

Given the potential for disputes over patent infringement, the patent's scope and claims must be clearly defined. The study on small claims patent courts highlights the need for efficient and cost-effective mechanisms for resolving patent disputes, which could impact the enforcement of this patent[5].

Practical Applications

Pharmaceutical Industry

The system is particularly useful in the pharmaceutical industry, where ensuring the authenticity of drugs is paramount. By using this system, pharmacies and healthcare providers can verify the legitimacy of medications before dispensing them to patients[1].

Supply Chain Integrity

Beyond pharmaceuticals, the system can be applied to various other industries where supply chain integrity is crucial. It helps in preventing counterfeit products from entering the market, thereby protecting consumers and maintaining trust in the supply chain.

Challenges and Future Directions

Technological Advancements

As technology advances, there may be opportunities to enhance the system's capabilities, such as integrating it with other tracking technologies like RFID or blockchain. These advancements could further strengthen the system's efficacy in supply chain management.

Regulatory Compliance

Ensuring compliance with regulatory requirements is essential. The system must adhere to standards set by regulatory bodies, especially in the pharmaceutical industry, to ensure widespread adoption and acceptance.

Key Takeaways

  • Capacitive Coupling System: The patent uses a capacitive coupling system to track and verify products.
  • Supply Chain Management: It is particularly useful in industries like pharmaceuticals for ensuring product authenticity.
  • Legal Considerations: Correct inventorship and clear scope of claims are crucial for patent enforceability.
  • Practical Applications: The system can be applied in various industries to maintain supply chain integrity.
  • Future Directions: Technological advancements and regulatory compliance are key areas for future development.

FAQs

What is the primary purpose of the United States Patent 9,941,931?

The primary purpose is to track and verify the authenticity of products, especially in the pharmaceutical industry, using a capacitive coupling system.

How does the capacitive coupling system work?

The system uses conductive materials deposited on a device, which are capacitively coupled to probes. These probes communicate with the device to verify its identity and authenticity.

What are the key components of the patent?

The key components include the device with conductive materials, the control module, and the probes powered by an AC source.

How does this patent impact supply chain management?

It ensures that only valid and authentic products are accepted, preventing counterfeit products from entering the supply chain.

What are the potential future directions for this technology?

Future directions include integrating the system with other tracking technologies and ensuring regulatory compliance to enhance its efficacy and adoption.

Sources

  1. US Patent and Trademark Office, "US9941931B2 - System for supply chain management," Google Patents.
  2. Oregon State University, "Determining Inventorship for US Patent Applications," AgSci.
  3. SSRN, "Patent Claims and Patent Scope," SSRN.
  4. USPTO, "Search for patents," USPTO.
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court," ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,941,931

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 RX Yes No 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 RX Yes Yes 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-004 Nov 13, 2017 RX Yes No 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-005 Nov 13, 2017 RX Yes No 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-006 Nov 13, 2017 RX Yes No 9,941,931 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,941,931

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010315128 ⤷  Subscribe
Brazil 112012010672 ⤷  Subscribe
Canada 2780361 ⤷  Subscribe
Canada 2980571 ⤷  Subscribe
Canada 3051659 ⤷  Subscribe
Chile 2012001174 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.